What is an enalapril tablet used for?

In the pharmaceutical industry, Enalapril Maleate is a cornerstone Angiotensin-Converting Enzyme (ACE) inhibitor. As a pharmacist and manufacturer, I classify this as a “Gold Standard” treatment for cardiovascular protection.

At your WHO-GMP facility in Mumbai, you likely manufacture this in 2.5 mg, 5 mg, 10 mg, and 20 mg strengths.

Primary Clinical Indications

Enalapril is a multi-purpose cardiovascular agent used for:

  • Hypertension (High Blood Pressure): It lowers blood pressure, which reduces the risk of stroke and myocardial infarction.

  • Heart Failure: It is used to manage symptomatic heart failure, often in combination with diuretics and digitalis. It has been shown to improve survival and reduce hospitalizations.

  • Asymptomatic Left Ventricular Dysfunction: It is prescribed for patients with a weakened heart (ejection fraction <35%) to prevent the development of overt heart failure.

Mechanism: The RAAS Interruption

Enalapril is a prodrug; after oral administration, it is bioactivated by the liver into Enalaprilat.

ACE Inhibition: Enalaprilat inhibits the Angiotensin-Converting Enzyme.

Angiotensin II Reduction: This prevents the conversion of Angiotensin I to Angiotensin II, a potent vasoconstrictor.

Vasodilation: With less Angiotensin II, blood vessels relax and widen (vasodilation), which lowers peripheral resistance and blood pressure.

Aldosterone Suppression: It also reduces the secretion of aldosterone, leading to decreased sodium and water retention.

The Pharmacist’s “Technical Warning”

As you promote your firm on digital and social platforms, providing these technical insights is essential for professional authority:

  • The “Dry Cough” Side Effect: A common side effect of ACE inhibitors is a persistent dry cough, caused by the accumulation of bradykinin in the lungs.

  • First-Dose Hypotension: Advise patients to take the first dose at bedtime to avoid dizziness or fainting from a sudden drop in blood pressure.

  • Hyperkalemia Risk: Enalapril can increase potassium levels; patients should be monitored, especially if they are taking potassium-sparing diuretics.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Prodrug” USP: On your multivendor marketplace, highlight the superior bioavailability and long half-life of your Enalapril tablets, which allows for convenient once-daily dosing.

  • Stability & Packaging: Enalapril Maleate is sensitive to moisture and can undergo degradation (cyclization to diketopiperazine). At our facility, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for export to Zone IVb tropical regions.

  • Niche Market Strategy: Position Enalapril as a cost-effective, clinically proven foundational therapy in your digital ads for emerging markets.

  • Dossier Support: We provide full CTD/eCTD Dossiers to support your firm’s registration in international markets like Southeast Asia, Africa, and the Middle East.

What is enalapril 2.5 mg used for?

In the pharmaceutical industry, Enalapril Maleate 2.5 mg is a potent, long-acting ACE (Angiotensin-Converting Enzyme) inhibitor. As a pharmacist, I characterize the 2.5 mg strength as the critical “initiation dose,” specifically used to prevent first-dose hypotension in high-risk patients or as a maintenance dose for pediatric populations and those with renal impairment.

Primary Clinical Uses

  • Hypertension Initiation: Used as the starting dose for treating high blood pressure, especially in patients also taking diuretics, to allow the body to adjust to the medication.

  • Heart Failure (Early Stage): Indicated for the management of symptomatic heart failure, usually in combination with diuretics and digitalis.

  • Left Ventricular Dysfunction: Prescribed for asymptomatic patients with a reduced ejection fraction ($LVEF < 35\%$) to improve survival and reduce the rate of hospitalization.

  • Diabetic Nephropathy: Frequently used off-label at low doses to protect kidney function in diabetic patients by reducing intraglomerular pressure.

  • Pediatric Hypertension: A standard dose for children where weight-based titration is required.

Mechanism of Action

Enalapril is a prodrug that is bioactivated in the liver to its active metabolite, Enalaprilat.

Enzyme Inhibition: It inhibits the ACE enzyme, which is responsible for converting Angiotensin I to Angiotensin II (a potent vasoconstrictor).

Vasodilation: By reducing Angiotensin II levels, it promotes systemic vasodilation, thereby lowering peripheral vascular resistance.

Aldosterone Reduction: It also reduces the secretion of aldosterone, leading to decreased sodium and water retention, which further lowers blood pressure and eases the workload on the heart.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Enalapril 2.5 mg is a high-precision cardiovascular product:

  • Micro-Dose Content Uniformity: Since 2.5 mg is a small amount of active ingredient per tablet, as a WHO-GMP manufacturer, we utilize validated wet granulation or direct compression with high-precision blending to ensure the API is perfectly distributed.

  • Stability for Global Trade: Enalapril Maleate is susceptible to hydrolysis and cyclization (forming a diketopiperazine impurity). We utilize Alu-Alu blister packaging or desiccants in HDPE bottles to ensure a 36-month shelf life in Zone IVb (hot/humid) climates.

  • Dossier Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data against the innovator (Vasotec/Renitec) to support our B2B partners in international registration.

  • Market Positioning: This “low-strength” SKU is essential for hospital tenders and cardiology clinics where precise titration is a clinical requirement.

Add to cart